Download Files:
Enpp-1-IN-16
SKU
HY-153335-10 mg
Category Reference compound
Tags Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease, Metabolic Enzyme/Protease, Phosphodiesterase (PDE)
$100 – $950
Products Details
Product Description
– Enpp-1-IN-16 (compound 54) is an ENPP1 inhibitor. Enpp-1-IN-16 has the potential to study cancer, especially in cases of high ENPP1 expression or elevated cytoplasmic DNA levels. Enpp-1-IN-16 can also be used in other diseases mediated by ENPP1, such as bacterial or viral infections, insulin resistance and type II diabetes, chondrocalcinosis and osteoarthritis, calcium pyrophosphate deposition disorder (CPPD), low Phosphatase disease and soft tissue calcification disorders[1].
Web ID
– HY-153335
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C23H32N4O4
References
– [1]Derek A Cogan, et al. Imino sulfanone inhibitors of enpp1. WO2021225969A1.
CAS Number
– 2289739-47-3
Molecular Weight
– 428.52
Compound Purity
– 99.11
SMILES
– O=C(N1CCC2(CCN(CC2)C3=C4C=C(OC)C(OC)=CC4=NC=N3)C1)OC(C)(C)C
Clinical Information
– No Development Reported
Research Area
– Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease
Solubility
– DMSO : 2 mg/mL (ultrasonic)
Target
– Phosphodiesterase (PDE)
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.